Casas, JP; Hingorani, AD; MacAllister, RJ; Smeeth, L; (2006) Progression of renal disease - can we forget about inhibition of the renin-angiotensin system? Authors' reply. Nephrology, dialysis, transplantation, 21 (9). pp. 2352-2353. ISSN 0931-0509 DOI: https://doi.org/10.1093/ndt/gfl316 Full text not available from this repository.

Hobart, J; Lamping, D; Fitzpatrick, R; Riazi, A; Thompson, A; (2001) The Multiple Sclerosis Impact Scale (MSIS-29) - A new patient- based outcome measure. Brain, 124 (Pt 5). pp. 962-73. ISSN 0006-8950 https://researchonline.lshtm.ac.uk/id/eprint/16934 Full text not available from this repository.

Kirwan, BA; Lubsen, J; de Brouwer, S; van Dalen, FJ; Pocock, SJ; Clayton, T; Danchin, N; Poole-Wilson, PA; (2008) Quality management of a large randomized double-blind multi-centre trial: The ACTION experience. Contemporary clinical trials, 29 (2). pp. 259-269. ISSN 1551-7144 DOI: https://doi.org/10.1016/j.cct.2007.10.001 Full text not available from this repository.

Pocock, SJ; (2003) The pros and cons of noninferiority trials. Fundamental & clinical pharmacology, 17 (4). pp. 483-490. ISSN 0767-3981 DOI: https://doi.org/10.1046/j.1472-8206.2003.00162.x Full text not available from this repository.